Drug-makers may have to declare `ex-factory' price on medicine packs

The proposal has perturbed pharma cos as it will put their manufacturing cost, profits and margins in the public domain.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news